LSV Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
349,900
-34,155
| -9% | -$1.01M | 0.02% | 389 |
|
|
2025
Q1 | $11.5M | Sell |
384,055
-6,396
| -2% | -$191K | 0.03% | 379 |
|
|
2024
Q4 | $11.2M | Sell |
390,451
-60,800
| -13% | -$1.74M | 0.03% | 394 |
|
|
2024
Q3 | $17.4M | Buy |
451,251
+70,700
| +19% | +$2.73M | 0.04% | 336 |
|
|
2024
Q2 | $12.3M | Hold |
380,551
| – | – | 0.03% | 412 |
|
|
2024
Q1 | $14.8M | Buy |
380,551
+248,751
| +189% | +$9.66M | 0.03% | 376 |
|
|
2023
Q4 | $4.06M | Buy |
131,800
+56,500
| +75% | +$1.74M | 0.01% | 545 |
|
|
2023
Q3 | $1.68M | Sell |
75,300
-195,300
| -72% | -$4.37M | ﹤0.01% | 632 |
|
|
2023
Q2 | $5.82M | Buy |
270,600
+29,800
| +12% | +$640K | 0.01% | 504 |
|
|
2023
Q1 | $5.78M | Buy |
240,800
+3,100
| +1% | +$74.4K | 0.01% | 500 |
|
|
2022
Q4 | $5.52M | Sell |
237,700
-1,900
| -0.8% | -$44.1K | 0.01% | 499 |
|
|
2022
Q3 | $3.84M | Sell |
239,600
-117,900
| -33% | -$1.89M | 0.01% | 542 |
|
|
2022
Q2 | $6.34M | Sell |
357,500
-2,500
| -0.7% | -$44.3K | 0.01% | 479 |
|
|
2022
Q1 | $7.33M | Sell |
360,000
-1,800
| -0.5% | -$36.7K | 0.01% | 480 |
|
|
2021
Q4 | $6.76M | Buy |
361,800
+214,900
| +146% | +$4.01M | 0.01% | 504 |
|
|
2021
Q3 | $2.9M | Buy |
+146,900
| New | +$2.9M | 0.01% | 612 |
|